NG-Amino-L-arginine . hydrochloride |  | | SYNONYMS | L-NAA . HCl |  |  | | PRODUCT LINE | Nitric Oxide Pathway |  |  | | PRODUCT FAMILIES | NOS Inhibitors (NOS Induction & Enzyme Activity) |  |  |  | | Ordering Information |  | | Product Numbers | Format | Size | Unit Price | Quantity |  | | ALX-106-014-M005 |
|
5 mg | | | |  | |  |
|  | | Product Specification |  | |
| FORMULA: | C6H15N5O2 . HCl |  |  | | | |
| MW: | 189.2 . 36.5 |  |  | | | |
| PURITY: | ≥97% (contains traces of L-ornithine and L-arginine) |  |  | | | |
| APPEARANCE: | White powder. |  |  | | | |
| SOLUBILITY: | Soluble in water. |  |  | | | |
| SHIPPING: | AMBIENT |  |  | | | |
| LONG TERM STORAGE: | +4°C |  |  | |  | | Product Description | Potent inhibitor of endothelial and inducible nitric oxide synthase (eNOS/NOS III and iNOS/NOS II). |
|  | | Product Specific Literature References | NG-amino-L-arginine: a new potent antagonist of L-arginine-mediated endothelium-dependent relaxation: J.M. Fukuto, et al.; BBRC 168, 458 (1990) Abstract Macrophage and endothelial cell nitric oxide synthesis: cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG- methylarginine: S.S. Gross, et al.; BBRC 170, 96 (1990) Abstract Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle: L.J. Ignarro, et al.; BBRC 170, 843 (1990) Abstract Nitric oxide synthesis in the CNS endothelium and macrophages differs in its sensitivity to inhibition by arginine analogues: L. Lambert, et al.; Life Sci. 48, 69 (1991) Abstract Comparison of the inhibitory potencies of N(G)-methyl-, N(G)-nitro- and N(G)-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release: H.M. Vargas, et al.; J. Pharmacol. Exp. Ther. 257, 1208 (1991) Abstract Inhibition of purified nitric oxide synthase from rat cerebellum and macrophage by L-arginine analogs: Y. Komori, et al.; Arch. Biochem. Biophys. 315, 213 (1994) Abstract Inactivation of nitric oxide synthase isoforms by diaminoguanidine and NG-amino-L-arginine: D.J. Wolff & A. Lubeskie; Arch. Biochem. Biophys. 325, 227 (1996) Abstract Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors: R. Bryk, et al.; Arch. Biochem. Biophys. 369, 243 (1999) Abstract Alteration of the heme prosthetic group of neuronal nitric-oxide synthase during inactivation by N(G)-amino-L-arginine in vitro and in vivo: J.L. Vuletich, et al.; Mol. Pharmacol. 62, 110 (2002) Full Text; http://molpharm.aspetjournals.org/cgi/reprint/62/1/110 Metabolism of aminoguanidine, diaminoguanidine, and NG-amino-L-arginine by neuronal NO-synthase and covalent alteration of the heme prosthetic group: A.J. Lee, et al.; Chem. Res. Toxicol. 18, 1927 (2005) Abstract |
| |  | | | RELATED PRODUCT GROUPS | |  |  |  | | |